A GLASGOW-BASED investment firm has reached a key milestone by completing its biggest investment year yet.
Some £10.5 million was invested across nine businesses in Kelvin Capital’s portfolio, which covers sectors like internet and app technology, biotech, life sciences, electronic manufacturing and medical technologies, in 2018.
The company has now entered its 10th year having secured £30.2m – made up from its syndicate members’ money, plus co-investment from others – for its portfolio.
John McNicol, director of Kelvin Capital, said: “2018 was a particularly strong investment year which saw the Kelvin Capital syndicate invest at record levels.
“The reputation of Kelvin Capital is also reaching across the whole of the UK, and overseas, with ambitious companies now approaching us seeking our investment and expertise. For any new investment, we are looking to support companies with international growth potential which are already revenue generating, or have commercial traction and are close to being revenue generating.”
Angus Hay, also a director of Kelvin Capital, added: “In the last three years, Kelvin Capital has raised its investment profile throughout the UK enabling companies to benefit from the wide sector experience amongst our membership. Since 2009 we have invested into 23 portfolio companies but 2018 has been the most active since we began.
“The fact that we have made eight follow-on investments, with other investment groups, is extremely exciting as these businesses have demonstrated strong potential to the investor community and reflects the maturing of the earlier investments in the Kelvin portfolio which are now close to market.”
The investment group, which was started by McNicol, now has over 200 UK-wide members and is seeing its portfolio grow.
Its 2018 follow-on investments included DNA manipulation firm Biotangents, innovative healthcare solutions company Clear Surgical and marine renewable energy business QED Naval.
Its new investment was in Novosound, which developed and patented a ground-breaking technique to mass-manufacture printable ultrasound sensors.
Why are you making commenting on The National only available to subscribers?
We know there are thousands of National readers who want to debate, argue and go back and forth in the comments section of our stories. We’ve got the most informed readers in Scotland, asking each other the big questions about the future of our country.
Unfortunately, though, these important debates are being spoiled by a vocal minority of trolls who aren’t really interested in the issues, try to derail the conversations, register under fake names, and post vile abuse.
So that’s why we’ve decided to make the ability to comment only available to our paying subscribers. That way, all the trolls who post abuse on our website will have to pay if they want to join the debate – and risk a permanent ban from the account that they subscribe with.
The conversation will go back to what it should be about – people who care passionately about the issues, but disagree constructively on what we should do about them. Let’s get that debate started!
Callum Baird, Editor of The National
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules here